Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

Gérard Socié, MD PhD, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Jeffrey Szer, MBBS, Alvaro Urbano-Ispizua, MD, Jaroslaw P. Maciejewski, MD, PhD, Robert A. Brodsky, MD, Monica Bessler, MD, PhD, Yuzuru Kanakura, MD, PhD, Wendell F. Rosse, MD, Gus Khursigara, PhD, Camille L. Bedrosian, MD, Peter Hillmen, MBChB, PhD

Blood (2012) 120 (21): 3480.

https://doi.org/10.1182/blood.V120.21.3480.3480

Published: 2012

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

Influence of Stem Cell Source On GvH and NRM: Comparison of 10/10 HLA-Matched Unrelated Donor (MUD) with 9/10 HLA-Mismatched Unrelated Donor (MMUD) and Unrelated Cord Blood (UCB) Transplants.

Clémence Granier, Emeline Masson, Lucie Biard, Raphael Porcher, PhD, Regis Peffault de la Tour, Marie Robin, Alienor Xhaard, Patricia Ribaud, Pascale Loiseau, Dominique Charron, PhD, Gérard Socié, MD PhD, Nathalie Dhedin, MD

Blood (2012) 120 (21): 3135.

https://doi.org/10.1182/blood.V120.21.3135.3135

Published: 2012

Journal Articles

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD, PhD, Myriam Labopin, Mohamed A. Kharfan-Dabaja, MD, Gérard Socié, MD PhD, Nicolaus Kröger, Didier Blaise, MD, Hendrik Veelken, MD PhD, Arancha Bermudez, Reuven Or, MD, Bruno Lioure, MD, Dietrich Beelen, Nathalie Fegueux, MD, Rose-Marie Hamljadi, Arnon Nagler, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 1929.

https://doi.org/10.1182/blood.V120.21.1929.1929

Published: 2012

Journal Articles

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Blood (2012) 120 (21): 1975.

https://doi.org/10.1182/blood.V120.21.1975.1975

Published: 2012

Journal Articles

Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, Ali Bazarbachi, MD, PhD, Rose-Marie Hamljadi, Didier Blaise, MD, Gérard Socié, MD PhD, Bruno Lioure, MD, Arancha Bermudez, MD, Dolores Caballero, MD, Reuven Or, MD, William Arcese, MD, Nathalie Fegueux, MD, Arnon Nagler, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 4153.

https://doi.org/10.1182/blood.V120.21.4153.4153

Published: 2012

Journal Articles

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Marie Sebert, Raphaël Porcher, Marie Robin, Lionel Ades, MD, PhD, Emmanuel Raffoux, Alienor Xhaard, Nathalie Dhedin, MD, Jerome Larghero, Chantal Himberlin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, MD, PhD, Gérard Socié, MD PhD, Regis Peffault de Latour

Blood (2012) 120 (21): 3103.

https://doi.org/10.1182/blood.V120.21.3103.3103

Published: 2012

Journal Articles

Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems

Jurjen Versluis, MD, Myriam Labopin, PhD, Dietger Niederwieser, Gérard Socié, MD PhD, Richard F Schlenk, MD, Noel Milpied, MD, Arnon Nagler, MD, Didier Blaise, MD, Vanderson Rocha, MD PhD, Jan Cornelissen, MD PhD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 734.

https://doi.org/10.1182/blood.V120.21.734.734

Published: 2012

Journal Articles

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Jeffrey Szer, MBBS, Petra Muus, MD, PhD, Alexander Roeth, MD, M.O Elebute, MD, FRCP, FRCPath, Antonio M. Risitano, MD, PhD, Hubert Schrezenmeier, MD, Jaroslaw P. Maciejewski, MD, PhD, Alvaro Urbano-Ispizua, MD, Carlos Manuel de Castro, III, MD, Gérard Socié, MD PhD, Robert A. Brodsky, MD

Blood (2012) 120 (21): 1260.

https://doi.org/10.1182/blood.V120.21.1260.1260

Published: 2012

Journal Articles

The Influence of Monosomal Karyotype On Survival in Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Survey On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Angelique V.M. Brands-Nijenhuis, MD, Myriam Labopin, MD, MS, Harry C. Schouten, MD, PhD, Liisa Volin, Gérard Socié, Jan J Cornelissen, MD PhD, Michel Attal, MD, Reza Tabrizi, MD, Jordi Esteve, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 158.

https://doi.org/10.1182/blood.V118.21.158.158

Published: 2011

Journal Articles

Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT

Renato Cunha, MD, Gerard Michel, Tracey O'Brien, Mair Pedro de Souza, Henrique Bittencourt, Gérard Socié, Pierre Bordigoni, Franco Locatelli, MD, Mouhab Ayas, Anna Paola Iori, Ajay J Vora, Jean-Hugues Dalle, José Sanches Toledo, Annalisa Ruggeri, MD, Mohamad Mohty, Christina Peters, MD, Eliane Gluckman, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 834.

https://doi.org/10.1182/blood.V118.21.834.834

Published: 2011

Journal Articles

tk;4Is There an Impact of HLA Mismatch Direction on Outcomes After Umbilical Cord Blood Transplantantion?

Renato Cunha, MD, Pascale Loiseau, Guillermo F Sanz, Gerard Michel, Anna Paola Iori, Gérard Socié, William Arcese, Annalisa Ruggeri, MD, Karim Boudjedir, Eliane Gluckman, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 835.

https://doi.org/10.1182/blood.V118.21.835.835

Published: 2011

Journal Articles

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia (AML) with 11q23 (MLL) Rearrangement (MLL-r AML). A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Arnaud Pigneux, MD, PhD, Myriam Labopin, MD, MS, Johann Maertens, MD, Ulrike Bacher, MD, Gérard Socié, Catherine Cordonnier, Noel-Jean Milpied, MD, Jean-Pierre Jouet, MD, Bernard Rio, MD, Didier Blaise, MD, Jordi Esteve, MD, Mohamad Mohty

Blood (2011) 118 (21): 498.

https://doi.org/10.1182/blood.V118.21.498.498

Published: 2011

Journal Articles

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Yvan Beaussant, Etienne Daguindau, MD, Aurore Vivot, Mohamad Mothy, MD, PhD, Herve Avet-Loiseau, MD, PhD, Damien Roos-Weil, MD, Mauricette Michallet, Nicole Raus, Didier Blaise, MD, Stephane Vigouroux, MD, Agnes Buzyn, MD, PhD, Gérard Socié, Nathalie Fegueux, Frederic Garban, MD, PhD, Eric Deconinck, MD, PhD

Blood (2011) 118 (21): 4113.

https://doi.org/10.1182/blood.V118.21.4113.4113

Published: 2011

Journal Articles

Endothelial Progenitor Cells in Paroxysmal Nocturnal Hemoglobinuria

Sophie Gandrille, PhD, Régis Peffault de Latour, Emeline Levionnois, Anna D. Petropoulou, MD, Isabelle Galy-Fauroux, Paula Rodriguez-Otero, Gérard Socié, Anne-Marie Fischer, MD, Dominique Helley, MD, PhD

Blood (2011) 118 (21): 2397.

https://doi.org/10.1182/blood.V118.21.2397.2397

Published: 2011

Journal Articles

Prospective Phase II Pilot Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline) with Ciclosporin for Patients with Acquired Aplastic Anemia and Matched Pair Analysis with Patients Treated with Horse ATG (Lymphoglobuline) and Ciclosporin: A Study From the EBMT Severe Aplastic Anemia Working Party (RATGAA07)

Judith C Marsh, Gérard Socié, Hubert Schrezenmeier, MD, Andre Tichelli, Antonio M. Risitano, Jakob R. Passweg, MD, Carlo Dufour, MD, Mahmoud Aljurf, MD, Hazza A Al-Zahrani, Rosi Oneto, Philip Sedgwick, Barrois Alain, Shahram Kordasti, Modupe Elebute, Ghulam J. Mufti, MD, Andrea Bacigalupo

Blood (2011) 118 (21): 2408.

https://doi.org/10.1182/blood.V118.21.2408.2408

Published: 2011

Journal Articles

Paternity Wishes in Young Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation. A Study of the Late Effects Working Party of the EBMT

Alicia Rovo, MD, Mahmoud Aljurf, M.D., Sandra Chiodi, MD, Simonetta Spinelli, MD, Nina Salooja, MD, Gülsan Sucak, MD, Ann E. Hunter, MBBS, FRCP, FRCPath, Tan Swee Kim, MD, Gérard Socié, Maria Teresa van Lint, Jakob R. Passweg, MD, Mutlu Arat, MD, Manuela Badoglio, André Tichelli, MD

Blood (2011) 118 (21): 2002.

https://doi.org/10.1182/blood.V118.21.2002.2002

Published: 2011

Journal Articles

Clinical Characteristics of Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in Pediatric Patients: A Comparison with Classic PNH in Adults. An International PNH Registry Study

Alvaro Urbano-Ispizua, MD, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, Gérard Socié, Jeffrey Szer, MBBS, FRACP, Robert A. Brodsky, MD, Monica Bessler, MD, PhD, Wendell F Rosse, MD, Yuzuru Kanakura, Gus Khursigara, PhD, Camille L Bedrosian, MD, Peter Hillmen, MBChB, PhD

Blood (2011) 118 (21): 2102.

https://doi.org/10.1182/blood.V118.21.2102.2102

Published: 2011

Journal Articles

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Severe Alpastic Anemia After Cyclophosphamide Plus Antithymocyte Globulin Conditioning Regimen,

Johanna Konopacki, MD, Raphael Porcher, Marie Robin, Sabine Bieri, Jean Michel Cayuela, MD, PhD, Jérome Larghero, Alienor Xhaard, Anna-Lisa Andreoli, MD, Nathalie Dhedin, MD, Anna D. Petropoulou, MD, Paula Rodriguez-Otero, MD, PhD, Patricia Ribaud, Helene Moins, MD, PhD, Mariyvonnick Carmagnat, Antoine Toubert, MD, PhD, Yves Chalandon, MD, Gérard Socié, Régis Peffault de Latour

Blood (2011) 118 (21): 4090.

https://doi.org/10.1182/blood.V118.21.4090.4090

Published: 2011

Journal Articles

Allogeneic Hematopoietic Peripheral Blood Stem-Cell Transplantation From HLA-Identical Siblings Versus Allelic-Matched Unrelated Donors (10/10 high resolution) in Patients with Acute Myeloid Leukemia and Myelodyplasic Syndrome After Reduced Intensity Conditioning,

Marie Robin, Raphael Porcher, Lionel Ades, Emmanuel Raffoux, MD, PhD, Nicolas Boissel, Jérome Larghero, Chantal Himberlin, Claude Gardin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, Gérard Socié, Régis Peffault de Latour

Blood (2011) 118 (21): 4132.

https://doi.org/10.1182/blood.V118.21.4132.4132

Published: 2011

NARROW

Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Influence of Stem Cell Source On GvH and NRM: Comparison of 10/10 HLA-Matched Unrelated Donor (MUD) with 9/10 HLA-Mismatched Unrelated Donor (MMUD) and Unrelated Cord Blood (UCB) Transplants.

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

The Influence of Monosomal Karyotype On Survival in Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Survey On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT

tk;4Is There an Impact of HLA Mismatch Direction on Outcomes After Umbilical Cord Blood Transplantantion?

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia (AML) with 11q23 (MLL) Rearrangement (MLL-r AML). A Retrospective Analysis From the Acute Leukemia Working Party of EBMT

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Endothelial Progenitor Cells in Paroxysmal Nocturnal Hemoglobinuria

Paternity Wishes in Young Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation. A Study of the Late Effects Working Party of the EBMT

Clinical Characteristics of Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in Pediatric Patients: A Comparison with Classic PNH in Adults. An International PNH Registry Study

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Severe Alpastic Anemia After Cyclophosphamide Plus Antithymocyte Globulin Conditioning Regimen,

Allogeneic Hematopoietic Peripheral Blood Stem-Cell Transplantation From HLA-Identical Siblings Versus Allelic-Matched Unrelated Donors (10/10 high resolution) in Patients with Acute Myeloid Leukemia and Myelodyplasic Syndrome After Reduced Intensity Conditioning,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only